Life-long functional regeneration of in vivo airway epithelium by the engraftment of airway basal stem cells
- PMID: 39501108
- DOI: 10.1038/s41596-024-01067-y
Life-long functional regeneration of in vivo airway epithelium by the engraftment of airway basal stem cells
Erratum in
-
Author Correction: Life-long functional regeneration of in vivo airway epithelium by the engraftment of airway basal stem cells.Nat Protoc. 2025 Mar 31. doi: 10.1038/s41596-025-01180-6. Online ahead of print. Nat Protoc. 2025. PMID: 40164751 No abstract available.
Abstract
Durable and functional regeneration of the airway epithelium in vivo with transplanted stem cells has the potential to reconstitute healthy tissue in diseased airways, such as in cystic fibrosis or primary ciliary dyskinesia. Here, we present detailed protocols for the preparation and culture expansion of murine primary and induced pluripotent stem cell-derived airway basal stem cells (iBCs) and methods for their intra-airway transplantation into polidocanol-conditioned murine recipients to achieve durable in vivo airway regeneration. Reconstitution of the airway tissue resident epithelial stem cell compartment of immunocompetent mice with syngeneic donor cells leverages the extensive self-renewal and multipotent differentiation properties of basal stem cells (BCs) to durably generate a broad diversity of mature airway epithelial lineages in vivo. Engrafted donor-derived cells re-establish planar cell polarity as well as functional ciliary transport. By using this same approach, human primary BCs or iBCs transplanted into NOD-SCID gamma recipient mice similarly display engraftment and multilineage airway epithelial differentiation in vivo. The time to generate mouse or human iBCs takes ~60 d, which can be reduced to ~20 d if previously differentiated cells are thawed from cryopreserved iBC archives. The tracheal conditioning regimen and cell transplantation procedure is completed in 1 d. A competent graduate student or postdoctoral trainee should be able to perform the procedures listed in this protocol.
© 2024. Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Similar articles
-
Airway epithelial stem cell renewal and differentiation: overcoming challenging steps towards clinical-grade tissue engineering.Stem Cell Res Ther. 2025 Jul 6;16(1):351. doi: 10.1186/s13287-025-04478-0. Stem Cell Res Ther. 2025. PMID: 40619403 Free PMC article.
-
Airway stem cell reconstitution by the transplantation of primary or pluripotent stem cell-derived basal cells.Cell Stem Cell. 2023 Sep 7;30(9):1199-1216.e7. doi: 10.1016/j.stem.2023.07.014. Epub 2023 Aug 24. Cell Stem Cell. 2023. PMID: 37625411 Free PMC article.
-
Targeted Pre-Conditioning and Cell Transplantation in the Murine Lower Respiratory Tract.Am J Respir Cell Mol Biol. 2025 Jun 20. doi: 10.1165/rcmb.2024-0597MA. Online ahead of print. Am J Respir Cell Mol Biol. 2025. PMID: 40540686
-
Systematic review of induced pluripotent stem cell technology as a potential clinical therapy for spinal cord injury.Cell Transplant. 2013;22(4):571-617. doi: 10.3727/096368912X655208. Epub 2012 Aug 27. Cell Transplant. 2013. PMID: 22944020
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
Cited by
-
THERAPIES FOR NEONATAL DISEASES OF THE SURFACTANT SYSTEM.Trans Am Clin Climatol Assoc. 2025;135:119-129. Trans Am Clin Climatol Assoc. 2025. PMID: 40771632 Free PMC article. Review.
-
A Differentiated Epithelial Layer Graft Improves Fibrosis and Survival in Airway Stenosis via IL-37.Allergy. 2025 May;80(5):1468-1472. doi: 10.1111/all.16452. Epub 2024 Dec 22. Allergy. 2025. PMID: 39711088 Free PMC article. No abstract available.
-
Engineered hydrogel biomaterials facilitate lung progenitor cell differentiation from induced pluripotent stem cells.Am J Physiol Lung Cell Mol Physiol. 2025 Mar 1;328(3):L379-L388. doi: 10.1152/ajplung.00419.2024. Epub 2025 Jan 30. Am J Physiol Lung Cell Mol Physiol. 2025. PMID: 39884665 Free PMC article.
References
Publication types
MeSH terms
Associated data
- Actions
Grants and funding
- R21 HD094012/HD/NICHD NIH HHS/United States
- R21HD094012/U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- P01HL170952/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- HAWKIN20XX2/Cystic Fibrosis Foundation (CF Foundation)
- U01HL134766/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R01HL139799/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R01HL095993/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R01 HL139799/HL/NHLBI NIH HHS/United States
- R01HL124392/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- R01 HL124392/HL/NHLBI NIH HHS/United States
- NO1: 75N92020C00005/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- PCTC Jumpstart Award/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- U01HL148692/U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- U01 HL134745/HL/NHLBI NIH HHS/United States
- U01 HL134766/HL/NHLBI NIH HHS/United States
- U01 HL148692/HL/NHLBI NIH HHS/United States
- R01 HL095993/HL/NHLBI NIH HHS/United States
- P01 HL170952/HL/NHLBI NIH HHS/United States
- R01 HL139799/HL/NHLBI NIH HHS/United States
- R01 HL124392/HL/NHLBI NIH HHS/United States
- R21 HD094012/HD/NICHD NIH HHS/United States
- 75N92020C00005/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources